A special focus on critical-need injectable drugs

Scroll

A special commitment to innovation

Through our deeply ingrained commitment to innovative R&D, Nexus Pharmaceuticals identifies those off-patent and unique molecules that can be developed, improved upon and commercialized so as to advance industry standards and deliver on the critical medical need.

We seek out difficult-to-formulate molecules with significant medical need

We innovate and improve the formulations to advance industry practice

We maintain the highest standards to deliver FDA-approved, life-saving drugs

Learn More

A special attention to quality

Through our partnerships with leading US-based industry suppliers and manufacturers, privately owned Nexus Pharmaceuticals can ensure consistent, dependable access to the highest-quality products. Our steadfast record of delivery ensures that our critical-need drugs are always available when and where they’re needed most.

About Us
See All Products

News

Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection
Nexus Pharmaceuticals announced today the immediate availability in the United States of Procainamide HCL Injection, USP. Nexus Pharmaceuticals' Procainamide... Read More

Nexus Pharmaceuticals Receives FDA Approval for Isoproterenol Injection
Nexus Pharmaceuticals announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug... Read More

See More News
Every member of the Nexus team has a deep passion for the creativity and innovation needed to advance the industry standards of drug development, and serve the daily needs of pharmacy buyers, clinicians and patients.
Roman Savchenko, Sales Analytics Manager